US › Healthcare

MDxHealth SA ADR (MDXH)

US · Healthcare · Diagnostics & Research

$0.67-1.32%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

$27.2M

Revenue YoY

+2.3%

Net profit

$-11.5M

EPS

$-0.18

EPS estimate

$-0.12

Net margin

-42.4%

EPS came in at -0.18 against a street estimate of -0.12 — a miss of 50.0%.

Key statistics

Market cap

$64.2M

Forward P/E

27.7

P/B

23.64

Book value

$-0.59

EPS (TTM)

$-0.67

52-week high

$5.33

52-week low

$0.40

50-day MA

$0.56

200-day MA

$2.03

Beta

-501,643.70

Analyst view

Analysts rate MDxHealth SA ADR a strong buy (6 buy, 0 hold, 0 sell out of 6) with an average price target of $1.80.

Shareholding

Insiders

22.14%

Institutions

45.19%

Largest institutional holders

Fund	Stake
Rhumbline Advisers	0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for MDxHealth SA ADR — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.